Source: Business Wire

Press Release: SiO2 Materials : Longhorn Vaccines & Diagnostics and SiO2 Materials Science Team Up to Develop 12 Millimeter Sample Transport Media for Higher Volumes of Automated Virus Testing

BETHESDA, Md. & AUBURN, Ala.--(BUSINESS WIRE)--Longhorn Vaccines & Diagnostics, an innovative molecular tool, assay and vaccine development company focused on serving unmet critical needs in both developed and developing nations, and SiO2 Materials Science, a privately-owned U.S. advanced materials science corporation introducing breakthrough disruptive technology for packaging biological pharmaceuticals and vaccines, today announced a partnership to produce and distribute PrimeStore® MTM i

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Yves Steffen's photo - CEO of SiO2

CEO

Yves Steffen

CEO Approval Rating

83/100

Read more